abstract |
The present invention relates to compounds of formula (I) wherein R, R and R are as defined in the claims. The compounds exhibit specific affinity for the GABAA receptor; therefore, they can be used for the treatment and prophylaxis of diseases associated with the modulation of α-GABA or α-GABA receptors. |